Bioretec’s roots go back to the 1970's, when Professor Pertti Törmälä started research at the Tampere University of Technology, which resulted in the world's first bioabsorbable implants to be used in orthopedic surgery. In 1985, he established Bioscience Ltd. to manufacture and commercialize bioabsorbable orthopedic medical devices. This lead to Bionx Implants Inc. that was successfully listed in NASDAQ New York in 1997. Bionx Implants Inc. was acquired by Conmed in 2003.
The spin-off company, BCI Bioabsorbable Concepts Oy was formed in 1998, and its name was changed to Bioretec Ltd. in 2003.
In 2019 Bioretec Ltd. acquired BRI.Tech GmbH located in Graz, Austria, a company that successfully developed and patented a magnesium based novel biocompatible and bioresorbable metal composition.
We are a Finnish material technology company focused on the development, manufacturing and marketing of bioabsorbable and bioactive surgical implants for orthopedic, trauma and sport medicine surgeries.
Bioretec has a very impressive team of professionals and expert advisors with combined 120 years of professional experience on core competencies. Long standing experience and knowhow covers understanding of materials, product development and production processes.
We continue to further develop the current materials and product lines as well as bringing to market completely new product lines for high load bearing clinical applications based on new materials and composites.
Bioretec’s mission is to develop and bring into clinical use innovative bioabsorbable products and surgical solutions which improve patient outcome, user friendliness and cost-efficiency in clinical care.
Bioretec’s vision is to be the leader in the field of bioabsorbable implants and continuously improve both technological and financial performance.